LAS VEGAS -- Skinvisible, Inc. announces it has signed a distribution agreement with Canadian-based Clara Laboratories Ltd. granting them the right to distribute Skinvisible's full line of proprietary Invisicare polymer-based delivery systems throughout the South Korean marketplace.
The agreement also gives Clara Laboratories access to Skinvisible's product formulations which incorporate the Invisicare delivery systems, including an antimicrobial hand sanitizer lotion and a range of skincare moisturizers and sunscreens. Proven advantages of the Skinvisible formulations include their ability to bond with the skin, holding active ingredients in place for extended periods and offering timed release. The formulations resist both wash-off and perspiration while providing longer persistence for skincare, sunscreen, and hand sanitizer products.
Of particular and immediate interest to Clara Laboratories, due to the imminent threat and spread of the SARS virus, is Skinvisible's patent-pending antimicrobial hand sanitizer formulation. Independent studies indicate that this formulation offers significant advantages over alcohol-based hand sanitizers marketed to kill bacteria and viruses on the hands. The Skinvisible formulation offers continuous, long-term kill of up to 4 hours per application, undiminished by hand washing or perspiration. In comparison, the alcohol gels typically provide instant protection but offer no long-term persistence.
"We see this agreement as a positive and rewarding new venture for Skinvisible," says Terry Howlett, president. "It makes the most sense to gain exposure in international markets through established local marketers and distributors," he continues, "and we are excited to see Skinvisible's patent-pending formulations introduced into South Korea which has significant market potential."
The founders and management of Clara Laboratories have extensive knowledge and connections within the South Korean market. Discussions are also presently underway for Clara Laboratories to potentially acquire certain rights to the antimicrobial hand sanitizer for the regions of China and Hong Kong where the SARS virus is most prevalent and threatening.
Skinvisible, Inc. is focused on the development of innovative topical polymer-based delivery systems and related technologies incorporating its patent-pending formula/process for combining hydrophilic and hydrophobic polymers into stable water emulsions.
Source: Skinvisible, Inc.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.